Host Tissue Damage by Phagocytes

Evidence continues to accumulate on the importance of neutrophils (PMNs) and phagocytes in the causation of tissue and endothelial injury that frequently accompanies the inflammatory response. Increased production of superoxide anions in combination with decreased endothelial antioxidant activity may contribute to the development of vascular disease including atherosclerosis, vasospasm, diabetic vascular complications, tissue damage in ischemia-reperfusion, and hypotension. Free radicals generated in the vascular wall may act directly on smooth muscle or interact with each other thus producing biologically active endogenous mediators. Derangement of macrophage function may occur in conditions characterized by protein malnutrition, thus leading to failure to develop a specific immunoresponse and to an increase in the production of oxygen intermediate radicals, which may cause tissue damage. A local inflammatory response followed by endothelial cell activation could also facilitate migration of immunocompetent cells into the parenchyma of grafted organs and stimulate dendritic cells in the graft. There is now convincing evidence that excessive and prolonged production of NO contributes to tissue damage in septicemia, ischemia/reperfusion injury, and other inflammatory conditions. There is also increasing evidence that the complement system plays an important role in tissue damage in association with phagocytes, e.g., in ischemia/reperfusion injury, carcinogenesis, and aging. It can therefore be surmised that phagocytic cells may act both as "friends" and as "foes" and that they are important mediators of tissue damage in a variety of conditions.

[1]  G. Ricevuti,et al.  The Pathophysiology of Phagocytes , 1989 .

[2]  Z. M. Chen,et al.  Platelet activation by polymorphonuclear leukocytes exposed to chemotactic agents. , 1990, The American journal of physiology.

[3]  W. Weintraub,et al.  Elevation of C-reactive protein in "active" coronary artery disease. , 1990, The American journal of cardiology.

[4]  D. Lanier,et al.  Reduction by cimetidine of serum parathyroid hormone levels in uremic patients. , 1980, The New England journal of medicine.

[5]  J. Mehta,et al.  Increased neutrophil elastase release in unstable angina pectoris and acute myocardial infarction. , 1990, Journal of the American College of Cardiology.

[6]  F. Rickles,et al.  The role of leukocytes in the activation of blood coagulation. , 1992, Seminars in hematology.

[7]  R. Tuma,et al.  Factors Influencing Leukocyte Adherence in Microvessels , 1977, Thrombosis and Haemostasis.

[8]  G. Mandell,et al.  Polymorphonuclear leukocytes: dedicated professional phagocytes. , 1983, The American journal of medicine.

[9]  G. Ricevuti,et al.  Membrane Glycoproteins in Superoxide Release from Neutrophils , 1990 .

[10]  G. Specchia,et al.  Increased Expression of Neutrophil and Monocyte Adhesion Molecules in Unstable Coronary Artery Disease , 1993, Circulation.

[11]  R. Faint Platelet-neutrophil interactions: their significance. , 1992, Blood reviews.

[12]  J. White,et al.  Platelet activation by fMLP-stimulated polymorphonuclear leukocytes: the activity of cathepsin G is not prevented by antiproteinases. , 1991, Blood.

[13]  B. Smith,et al.  Activated and unactivated platelet adhesion to monocytes and neutrophils. , 1991, Blood.

[14]  E. Engvall,et al.  Enzyme-linked immunosorbent assay. II. Quantitative assay of protein antigen, immunoglobulin G, by means of enzyme-labelled antigen and antibody-coated tubes. , 1971, Biochimica et biophysica acta.

[15]  N. Benowitz Drug therapy. Pharmacologic aspects of cigarette smoking and nicotine addiction. , 1988, The New England journal of medicine.

[16]  P. Venge,et al.  Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study. , 1992, The Journal of thoracic and cardiovascular surgery.

[17]  H. Jacob,et al.  Cholesterol and atheroma lipids activate complement and stimulate granulocytes. A possible mechanism for amplification of ischemic injury in atherosclerotic states. , 1981, The Journal of laboratory and clinical medicine.

[18]  W. Hörl,et al.  Neutrophil activation in acute renal failure and sepsis. , 1990, Archives of surgery.

[19]  M. Curtis,et al.  Endogenous chemical mediators of ventricular arrhythmias in ischaemic heart disease. , 1993, Cardiovascular research.

[20]  G. Schmid-Schönbein,et al.  Role of leukocytes in response to acute myocardial ischemia and reflow in dogs. , 1986, The American journal of physiology.

[21]  W. Dreyer,et al.  Neutrophil adherence to isolated adult canine myocytes. Evidence for a CD18-dependent mechanism. , 1990, The Journal of clinical investigation.

[22]  E. Dejana,et al.  Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. , 1991, Haematologica.

[23]  G. Ricevuti,et al.  Definition of CD 11a, b, c, and CD 18 glycoproteins on chemotactically deficient granulocyte membranes in patients affected by myeloid disorders. , 1989, Acta haematologica.

[24]  M. Klempner,et al.  The effect of hemodialysis and C5a des arg on neutrophil subpopulations. , 1980, Blood.

[25]  G. Specchia,et al.  Granulocyte function in coronary artery disease. , 1991, The American journal of cardiology.

[26]  Rickles Fr,et al.  The role of leukocytes in the activation of blood coagulation. , 1992 .

[27]  R. Guidoin,et al.  Effects of thrombocytopenia and shear rate on neutrophil and platelet deposition on endothelial and medial arterial surfaces. , 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

[28]  S. Abramson,et al.  The neutrophil in rheumatoid arthritis. , 1995, Rheumatic diseases clinics of North America.

[29]  P. Fratino,et al.  New trends in coronary artery disease: the role of granulocyte activation. , 1989, Atherosclerosis.

[30]  Robert A. Lewis,et al.  Leukotrienes and other products of the 5-lipoxygenase pathway. Biochemistry and relation to pathobiology in human diseases. , 1990, The New England journal of medicine.

[31]  H. Makker,et al.  Mechanisms of exercise‐induced asthma , 1994, European journal of clinical investigation.

[32]  M. Boogaerts,et al.  Enhancement of granulocyte-endothelial cell adherence and granulocyte-induced cytotoxicity by platelet release products. , 1982, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Covell,et al.  Granulocytes cause reperfusion ventricular dysfunction after 15-minute ischemia in the dog. , 1987, Circulation research.

[34]  S. Neumann,et al.  “PMN-Elastase Assay”: Enzyme Immunoassay for Human Polymorphonuclear Elastase Complexed with α1-Proteinase Inhibitor , 1984, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie.

[35]  J I Gallin,et al.  Current concepts: immunology. Neutrophils in human diseases. , 1987, The New England journal of medicine.

[36]  Cell Adhesion Molecules and the Kidney , 1994 .

[37]  G. Specchia,et al.  Granulocyte activation after coronary angioplasty in humans. , 1990, Circulation.

[38]  G. Ricevuti,et al.  The Biology of phagocytes in health and disease , 1987 .

[39]  A. Böyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. , 1968, Scandinavian journal of clinical and laboratory investigation. Supplementum.

[40]  P. Serruys,et al.  Effect of coronary occlusion during percutaneous transluminal angioplasty in humans on left ventricular chamber stiffness and regional diastolic pressure-radius relations. , 1986, Journal of the American College of Cardiology.

[41]  B. Babior,et al.  Biological defense mechanisms. The production by leukocytes of superoxide, a potential bactericidal agent. , 1973, The Journal of clinical investigation.

[42]  P. Venge,et al.  Inflammatory system activation during cardiopulmonary bypass as an indicator of biocompatibility: a randomized comparison of bubble and membrane oxygenators. , 1990, Scandinavian journal of thoracic and cardiovascular surgery.

[43]  E. Braunwald,et al.  The Stunned Myocardium: Prolonged, Postischemic Ventricular Dysfunction , 1982, Circulation.

[44]  J. Harlan Consequences of Leukocyte-Vessel Wall Interactions in Inflammatory and Immune Reactions , 1987, Seminars in thrombosis and hemostasis.

[45]  M. Cohen,et al.  A defect in the oxidative metabolism of human polymorphonuclear leukocytes that remain in circulation early in hemodialysis. , 1982, Blood.

[46]  E. Plow Leukocyte elastase release during blood coagulation. A potential mechanism for activation of the alternative fibrinolytic pathway. , 1982, The Journal of clinical investigation.

[47]  S. Werns,et al.  Leukocytes, oxygen radicals, and myocardial injury due to ischemia and reperfusion. , 1988, Free radical biology & medicine.

[48]  D. D. de Bono Free radicals and antioxidants in vascular biology: the roles of reaction kinetics, environment and substrate turnover. , 1994, QJM : monthly journal of the Association of Physicians.

[49]  G. Ronquist,et al.  Bubble and membrane oxygenators--comparison of postoperative organ dysfunction with special reference to inflammatory activity. , 1990, Scandinavian journal of thoracic and cardiovascular surgery.

[50]  J. Baars,et al.  The activation of polymorphonuclear neutrophils and the complement system during immunotherapy with recombinant interleukin-2. , 1992, British Journal of Cancer.

[51]  G. Camussi,et al.  The release of platelet-activating factor from human endothelial cells in culture. , 1983, Journal of immunology.

[52]  S. Weiss Tissue destruction by neutrophils. , 1989, The New England journal of medicine.

[53]  S. de Servi,et al.  Granulocytes and Myocardial Ischemia , 1989 .

[54]  J. Mehta,et al.  Neutrophil function in ischemic heart disease. , 1989, Circulation.

[55]  B. Månsson,et al.  Cytidine deaminase activity in synovial fluid of patients with rheumatoid arthritis: relation to lactoferrin, acidosis, and cartilage proteoglycan release. , 1990, Annals of the rheumatic diseases.

[56]  G. Specchia,et al.  Role of granulocytes in endothelial injury in coronary heart disease in humans. , 1991, Atherosclerosis.

[57]  S. Berliner,et al.  The leukergy test in patients with ischemic heart disease. , 1986, American heart journal.

[58]  R. Snyderman,et al.  Activation of the respiratory burst enzyme in human polymorphonuclear leukocytes by chemoattractants and other soluble stimuli. Evidence that the same oxidase is activated by different transductional mechanisms. , 1983, The Journal of clinical investigation.

[59]  B. Lucchesi Role of neutrophils in ischemic heart disease: pathophysiologic role in myocardial ischemia and coronary artery reperfusion. , 1987, Cardiovascular clinics.

[60]  L. Harker,et al.  Role of platelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty. , 1987, The American journal of cardiology.

[61]  E. Jaffe,et al.  Human leukocyte cathepsin G and elastase specifically suppress thrombin-induced prostacyclin production in human endothelial cells. , 1989, Blood.

[62]  D. Altieri,et al.  Coagulation assembly on leukocytes in transmembrane signaling and cell adhesion. , 1993, Blood.

[63]  G. Weissmann,et al.  Release of inflammatory mediators from stimulated neutrophils. , 1980, The New England journal of medicine.

[64]  G. Specchia,et al.  Clinical and angiographic correlates of leukocyte activation in unstable angina. , 1995, Journal of the American College of Cardiology.

[65]  S. Popoff,et al.  Animal models of osteopetrosis: the impact of recent molecular developments on novel strategies for therapeutic intervention. , 1996, Molecular medicine today.

[66]  H. Broxmeyer,et al.  Regulation of human bone marrow lactoferrin and myeloperoxidase gene expression by tumor necrosis factor-alpha. , 1991, Journal of immunology.

[67]  M. J. Moore,et al.  Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. , 1980, The New England journal of medicine.

[68]  B. Diamond,et al.  Autoimmunity in heart disease: mechanisms and genetic susceptibility. , 1996, Molecular medicine today.

[69]  V. Fuster,et al.  Restenosis after arterial angioplasty: a hemorrheologic response to injury. , 1987, The American journal of cardiology.

[70]  A. Bøyum,et al.  Isolation of mononuclear cells and granulocytes from human blood. , 1968 .

[71]  J. V. van Mourik,et al.  Characterization of the enhanced adhesion of neutrophil leukocytes to thrombin-stimulated endothelial cells. , 1990, Journal of immunology.

[72]  E. C. Slater,et al.  The extinction coefficient of cytochrome c. , 1962, Biochimica et biophysica acta.

[73]  J. Harlan Leukocyte-endothelial interactions. , 1985, Blood.

[74]  K. Przyklenk Oxygen-derived free radicals and 'stunned myocardium'. , 1988, Free radical biology & medicine.

[75]  G. Specchia,et al.  Increased neutrophil aggregability in coronary artery disease. , 1990, European heart journal.

[76]  G. Specchia,et al.  Transcardiac release of leukotriene C4 by neutrophils in patients with coronary artery disease. , 1991, Journal of the American College of Cardiology.

[77]  B. Brando,et al.  Nationwide quality control trial on lymphocyte immunophenotyping and flow cytometer performance in Italy. , 1993, Cytometry.

[78]  R E Vlietstra,et al.  Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. , 1984, The American journal of cardiology.